Sharemaestro company-news research for IQVIA Holdings Inc (IQV), showing current tone, evidence confidence, direct company coverage, sector and industry context, completed price response and the source headlines used on the page. Scores describe published news evidence. Confidence describes the amount, freshness, source breadth and direct company relevance of that evidence. Price context is shown separately.

NYSE United States Measured evidence

Company news sentiment

IQV news sentiment

IQVIA Holdings Inc

Company headlines compared by relevance, subject, source independence, tone and the market's completed price response.

Weighted tone56Neutral is 50
Balanced news tone 58/100 evidence confidence 100% direct company focus 3 current stories across 2 publishers
Latest weekly closeUSD 238.70week of 7 Aug 2026
Dominant catalystEarnings66/100 classification confidence
News data statusHealthy0 duplicate stories removed

Current company news

Balanced read

Balanced news tone is drawn from 3 fresh independent stories, including 3 company-specific items across 2 publishers.

Latest source headline IQV Stock Gains 42% in 3 Months: Here's What You Should Know finance.yahoo.com · 12 Aug 2026 13:09

What supports the read

Direct evidence

3 current stories are mapped specifically to IQV.

Narrative agreement

Cross-story agreement is 73/100, indicating a comparatively coherent tape.

What tempers the read

Source breadth

Only 2 publishers currently contribute to the measured read.

56/100
Weighted toneBalanced news tone
58/100
Evidence confidencebuilding confidence
100%/100
Company focus3 direct stories
73/100
Evidence agreement27/100 dispersion

News history

Tone and story flow over 21 days

Daily weighted evidence
09 Aug: 1 stories11 Aug: 1 stories12 Aug: 1 stories 09 Aug: tone 33, 1 stories11 Aug: tone 39, 1 stories12 Aug: tone 90, 1 stories 95505
24 Jul03 Aug13 Aug
Weighted toneStory volumeNeutral 50

Evidence confidence

What supports the score

Measured separately from tone

Confidence rises through sample depth, independent publishers, direct company relevance, freshness and agreement. A high or low tone score is not itself evidence of reliability.

Sample depth33
2.62 effective stories
Source breadth40
2 independent publishers
Direct relevance100
company-specific evidence share
Freshness76
recency-weighted evidence
Agreement73
cross-story consistency
Source independence28
lower publisher concentration

Price context

Sentiment against the 26-week price path

Balanced read

News tone and price action are not far from neutral.

13 Feb 2026: close 166.94, indexed 100.020 Feb 2026: close 165.62, indexed 99.227 Feb 2026: close 178.81, indexed 107.106 Mar 2026: close 174.49, indexed 104.513 Mar 2026: close 164.72, indexed 98.720 Mar 2026: close 166.07, indexed 99.527 Mar 2026: close 163.85, indexed 98.103 Apr 2026: close 173.26, indexed 103.810 Apr 2026: close 167.34, indexed 100.217 Apr 2026: close 176.46, indexed 105.724 Apr 2026: close 162.28, indexed 97.201 May 2026: close 157.77, indexed 94.508 May 2026: close 178.71, indexed 107.115 May 2026: close 169.12, indexed 101.322 May 2026: close 167.9, indexed 100.629 May 2026: close 182.21, indexed 109.105 Jun 2026: close 183.45, indexed 109.912 Jun 2026: close 181.46, indexed 108.719 Jun 2026: close 167.77, indexed 100.526 Jun 2026: close 191.14, indexed 114.503 Jul 2026: close 207.04, indexed 124.010 Jul 2026: close 207.85, indexed 124.517 Jul 2026: close 206.26, indexed 123.624 Jul 2026: close 208.05, indexed 124.631 Jul 2026: close 235.02, indexed 140.807 Aug 2026: close 238.7, indexed 143.0 20 Jun 2026: sentiment 5221 Jun 2026: sentiment 5122 Jun 2026: sentiment 5622 Jun 2026: sentiment 5622 Jun 2026: sentiment 5622 Jun 2026: sentiment 5422 Jun 2026: sentiment 5423 Jun 2026: sentiment 5423 Jun 2026: sentiment 5323 Jun 2026: sentiment 5325 Jun 2026: sentiment 5526 Jun 2026: sentiment 5426 Jun 2026: sentiment 5527 Jun 2026: sentiment 5427 Jun 2026: sentiment 5227 Jun 2026: sentiment 5427 Jun 2026: sentiment 5428 Jun 2026: sentiment 5528 Jun 2026: sentiment 5528 Jun 2026: sentiment 5629 Jun 2026: sentiment 5630 Jun 2026: sentiment 5501 Jul 2026: sentiment 5501 Jul 2026: sentiment 5503 Jul 2026: sentiment 5403 Jul 2026: sentiment 5604 Jul 2026: sentiment 5704 Jul 2026: sentiment 5205 Jul 2026: sentiment 5706 Jul 2026: sentiment 5808 Jul 2026: sentiment 6109 Jul 2026: sentiment 6210 Jul 2026: sentiment 6010 Jul 2026: sentiment 5911 Jul 2026: sentiment 5813 Jul 2026: sentiment 6014 Jul 2026: sentiment 5915 Jul 2026: sentiment 6019 Jul 2026: sentiment 5919 Jul 2026: sentiment 5921 Jul 2026: sentiment 5821 Jul 2026: sentiment 5822 Jul 2026: sentiment 5523 Jul 2026: sentiment 5523 Jul 2026: sentiment 5431 Jul 2026: sentiment 5901 Aug 2026: sentiment 55
13 Feb15 May07 Aug
Weekly close, indexedSentiment score
26-week price+43.0%latest close 238.7
Sentiment change+3available snapshot window
One-week response+1.6%Price digesting
Fair-value position+17.4%Near fair-value range

News subjects

What is shaping the score

Earnings
Earnings662 stories · 67%
Market update391 stories · 33%

Source mix

Where the evidence comes from

28/100 independence
finance.yahoo.com662 stories · 67%
seekingalpha.com391 stories · 33%

Recurring subjects

Subjects appearing most often

Current evidence
Guidance2Earnings Growth2Earnings2Treasuries1Net Income1Intrinsic Value1Gene Therapy1Energy1Economic Calendar1Earnings Surprise1

Earlier readings

How the score has changed

50 is the neutral baseline
ConstructiveBalanced or withheldCautious

Source headlines

The news behind the score

Showing 1-3 of 3

Every row shows the public evidence used to understand the read. Direct company stories carry more weight than industry or sector context; duplicate coverage is consolidated before scoring.

#190Tone
finance.yahoo.comDirect company coverage

IQV Stock Gains 42% in 3 Months: Here's What You Should Know

IQVIA Holdings Inc. IQV stock has rallied over the past three months. The company's shares have jumped 41.5%, outperforming the industry's 17.2% growth and the Zacks S&P 500 Composite's 3.4% uptick. 3-Month Share Price PerformanceZacks Investment Research Image Source: Zacks Investment Research Let us delve into the factors that have contributed to the company's outperformance. Record Net Bookings & Solid Backlogs IQVIA's net new bookings were $3.2 billion for research and development solutions (R&DS) in the second quarter of 2026. It marked 19% year-over-year growth, resulting in a book-to-bi

EarningsEarnings GrowthEarnings Per ShareEarnings SurpriseGuidanceIntrinsic Value
Published
12 Aug 2026 13:09
Catalyst
Earnings
Evidence role
Direct company coverage
Duplicates
1 consolidated
#239Tone
seekingalpha.comDirect company coverage

Stock futures edge lower as traders focus on Strait of Hormuz reopening

[The New York Stock Exchange on the Wall street sign] Dmitry Vinogradov Stock index futures were lower on Tuesday as traders continued to focus on developments related to the reopening of the Strait of Hormuz. Dow futures (INDU [https://seekingalpha.com/symbol/INDU]) -0.17%, S&P 500 futures (SPX [https://seekingalpha.com/symbol/SPX]) -0.0321%, and Nasdaq futures (US100:IND) -0.13%. The 2-year Treasury yield (US2Y [https://seekingalpha.com/symbol/US2Y]) rose 2 basis points to 4.27%, the benchmark 10-year Treasury yield (US10Y [https://seekingalpha.com/symbol/US10Y]) rose 2 basis points to 4.74%

Economic CalendarEnergyTreasuries
Published
11 Aug 2026 08:04
Catalyst
Market update
Evidence role
Direct company coverage
Duplicates
1 consolidated
#333Tone
finance.yahoo.comDirect company coverage

How Investors Are Reacting To IQVIA Holdings (IQV) Cardiac Gene Therapy Push And Higher 2026 Revenue Outlook

In late July and early August 2026, IQVIA Holdings and Medera announced a collaboration pairing IQVIA's global clinical and commercialization infrastructure with Medera's Sardocor and Novoheart cardiac gene therapy and human-based drug discovery platforms, alongside IQVIA's second-quarter results, raised full-year 2026 revenue guidance to between US$17.28 billion and US$17.48 billion, and continued share repurchases. The partnership's focus on AAV-based cardiac gene therapies and Novoheart's mini-Heart platform under the FDA Modernization Act 2.0 highlights IQVIA's deeper push into cutting-edg

AIEarningsEarnings GrowthGene TherapyGuidanceNet Income
Published
09 Aug 2026 15:11
Catalyst
Earnings
Evidence role
Direct company coverage
Duplicates
1 consolidated

How the page works

How to read the score

Tone is directional

It describes the weighted balance of qualifying headlines. A score of 50 can mean a balanced tape or that direction has been withheld for insufficient evidence; the status label distinguishes them.

Confidence is separate

Confidence measures depth, source breadth, direct relevance, freshness and agreement. It does not rise merely because the tone is extreme.

Price is confirmation

Weekly price response, trend and fair-value position test whether the market is accepting or rejecting the news. They never rewrite the news score.

Classification, not prediction

The page describes completed evidence available at the stated time. It is research context, not a forecast, recommendation, target or execution instruction.

Evidence context